- Home
- TNDM vs CRMD Comparison
TNDM vs CRMD Comparison
Compare TNDM & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNDM | CRMD |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 876.7M |
| IPO Year | 2013 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TNDM | CRMD |
|---|---|---|
| Price | $21.24 | $11.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $22.00 | $17.43 |
| AVG Volume (30 Days) | 2.3M | ★ 3.2M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | ★ $1,007,001,000.00 | $214,303,672.00 |
| Revenue This Year | $8.59 | $627.89 |
| Revenue Next Year | $10.19 | $40.95 |
| P/E Ratio | ★ N/A | $5.15 |
| Revenue Growth | 17.87 | ★ 1647.67 |
| 52 Week Low | $9.98 | $5.60 |
| 52 Week High | $38.28 | $17.43 |
Technical Indicators
Market Signals| Indicator | TNDM | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 64.80 | 56.57 |
| Support Level | $20.20 | $9.20 |
| Resistance Level | $21.36 | $12.10 |
| Average True Range (ATR) | 1.17 | 0.51 |
| MACD | -0.12 | 0.21 |
| Stochastic Oscillator | 73.12 | 67.18 |
Price Performance
Historical ComparisonAbout TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.